These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Sebelipase alfa improves atherogenic biomarkers in adults and children with lysosomal acid lipase deficiency. Wilson DP; Friedman M; Marulkar S; Hamby T; Bruckert E J Clin Lipidol; 2018; 12(3):604-614. PubMed ID: 29628368 [TBL] [Abstract][Full Text] [Related]
9. Novel LIPA mutations in Mexican siblings with lysosomal acid lipase deficiency. Santillán-Hernández Y; Almanza-Miranda E; Xin WW; Goss K; Vera-Loaiza A; Gorráez-de la Mora MT; Piña-Aguilar RE World J Gastroenterol; 2015 Jan; 21(3):1001-8. PubMed ID: 25624737 [TBL] [Abstract][Full Text] [Related]
10. Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants. Pisciotta L; Tozzi G; Travaglini L; Taurisano R; Lucchi T; Indolfi G; Papadia F; Di Rocco M; D'Antiga L; Crock P; Vora K; Nightingale S; Michelakakis H; Garoufi A; Lykopoulou L; Bertolini S; Calandra S Atherosclerosis; 2017 Oct; 265():124-132. PubMed ID: 28881270 [TBL] [Abstract][Full Text] [Related]
11. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies. Vijay S; Brassier A; Ghosh A; Fecarotta S; Abel F; Marulkar S; Jones SA Orphanet J Rare Dis; 2021 Jan; 16(1):13. PubMed ID: 33407676 [TBL] [Abstract][Full Text] [Related]
12. Lysosomal acid lipase deficiency--an under-recognized cause of dyslipidaemia and liver dysfunction. Reiner Ž; Guardamagna O; Nair D; Soran H; Hovingh K; Bertolini S; Jones S; Ćorić M; Calandra S; Hamilton J; Eagleton T; Ros E Atherosclerosis; 2014 Jul; 235(1):21-30. PubMed ID: 24792990 [TBL] [Abstract][Full Text] [Related]
13. Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: Final results of the ARISE study. Burton BK; Feillet F; Furuya KN; Marulkar S; Balwani M J Hepatol; 2022 Mar; 76(3):577-587. PubMed ID: 34774639 [TBL] [Abstract][Full Text] [Related]
14. Does Lysosomial Acid Lipase Reduction Play a Role in Adult Non-Alcoholic Fatty Liver Disease? Baratta F; Pastori D; Polimeni L; Tozzi G; Violi F; Angelico F; Del Ben M Int J Mol Sci; 2015 Nov; 16(12):28014-21. PubMed ID: 26602919 [TBL] [Abstract][Full Text] [Related]
15. Sebelipase Alfa: A Review in Lysosomal Acid Lipase Deficiency. Frampton JE Am J Cardiovasc Drugs; 2016 Dec; 16(6):461-468. PubMed ID: 27878737 [TBL] [Abstract][Full Text] [Related]
16. [Lysosomal acid lipase deficiency (LAL-D) : Diagnostic and therapeutic options in an underdiagnosed disease]. Synoracki S; Kathemann S; Schmid KW; Jastrow H; Baba HA Pathologe; 2018 May; 39(3):249-254. PubMed ID: 29234937 [TBL] [Abstract][Full Text] [Related]
17. Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease. Bernstein DL; Hülkova H; Bialer MG; Desnick RJ J Hepatol; 2013 Jun; 58(6):1230-43. PubMed ID: 23485521 [TBL] [Abstract][Full Text] [Related]
18. Pediatric patients with lysosomal acid lipase deficiency. Suarez-Zamora DA; Rojas-Rojas MM; Ordoñez-Guerrero F; Mugnier-Quijano J; Lopez-Panqueva R Rev Esp Patol; 2023; 56(2):113-118. PubMed ID: 37061237 [TBL] [Abstract][Full Text] [Related]
19. Reduced lysosomal acid lipase activity: A new marker of liver disease severity across the clinical continuum of non-alcoholic fatty liver disease? Baratta F; Pastori D; Ferro D; Carluccio G; Tozzi G; Angelico F; Violi F; Del Ben M World J Gastroenterol; 2019 Aug; 25(30):4172-4180. PubMed ID: 31435171 [TBL] [Abstract][Full Text] [Related]